Synthesis and antitumor activity of 4- tert-butyl-5-benzyl-2-benzyliminothiazoles

Jiao Ye , Shenyi Qiu , Aixi Hu , Junmei Peng , Zhi Qin

Chemical Research in Chinese Universities ›› 2014, Vol. 30 ›› Issue (1) : 49 -54.

PDF
Chemical Research in Chinese Universities ›› 2014, Vol. 30 ›› Issue (1) : 49 -54. DOI: 10.1007/s40242-013-3345-6
Article

Synthesis and antitumor activity of 4- tert-butyl-5-benzyl-2-benzyliminothiazoles

Author information +
History +
PDF

Abstract

A series of novel Schiff bases including 4-tert-butyl-5-benzyl-2-benzyliminothiazoles was synthesized by reacting the aromatic aldehydes with the corresponding 2-aminothiazoles. The antitumor bioassay revealed that compounds 2n and 2m exhibited potent cytotoxicity against human cervix cancer(HeLa) cell line with IC50 values of 0.001 and 0.007 mmol/L, respectively. The preliminary structure-activity relationship(SAR) investigations and the apoptosis evaluation suggest that 4-tert-butyl-5-benzyl-2-benzyliminothiazoles may be a satisfactory backbone for antitumor activity, and compound 2n can serve as an attractive candidate for the development of novel apoptosis in anticancer treatment.

Keywords

2-Aminothiazole / Schiff base / Antitumor activity

Cite this article

Download citation ▾
Jiao Ye, Shenyi Qiu, Aixi Hu, Junmei Peng, Zhi Qin. Synthesis and antitumor activity of 4- tert-butyl-5-benzyl-2-benzyliminothiazoles. Chemical Research in Chinese Universities, 2014, 30(1): 49-54 DOI:10.1007/s40242-013-3345-6

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Holla B S, Malini KV, Rao B S, Sarojini B K, Kumari N S. Eur. J. Med. Chem., 2003, 38: 313.

[2]

Li M, Sim Y, Ham S W. Bull. Korean Chem. Soc., 2010, 31: 1463.

[3]

Souza MV N D. J. Sulfur Chem., 2005, 26: 429.

[4]

Gorczynski M J, Leal R M, Mooberry S L, Bushweller J H, Brown M L. Bioorg. Med. Chem., 2004, 12: 1029.

[5]

Misra R N, Xiao H Y, Williams D K, Kim K S, Lu S F, Keller K A, Mulheron J G, Batorsky R, Tokarski J S, Sack J S, Kimball S D, Lee F Y, Webster K R. Bioorg. Med. Chem. Lett., 2004, 14: 2973.

[6]

Shao L, Zhou X, Jin Z, Fang J X. Heteroat. Chem., 2008, 19: 2.

[7]

Steinberg M. Clinical Therapeutics, 2007, 29: 2289.

[8]

Lombardo L J, Lee F Y, Chen P, Norris D, Barrish J C, Behnia K, Castaneda S, Cornelius L A M, Das J, Doweyko A M, Fairchild C, Hunt J T, Inigo I, Johnston K, Kamath A, Kan D, Klei H, Marathe P, Pang S, Peterson R, Pitt S, Schieven G L, Schmidt R J, Tokarski J, Wen M L, Wityak J, Borzilleri R M. J. Med. Chem., 2004, 47: 6658.

[9]

Walsby E, Lazenby M, Pepper C, Burnett A K. Leukemia, 2011, 25: 411.

[10]

Özkay Y, İncesu Z, Işıkdağ, Yeşilkaya M. Cell Biochem. Funct., 2008, 26: 102.

[11]

Wang P H, Keck J G, Lien E J, Lai M M C. J. Med. Chem., 1990, 33: 608.

[12]

Tang A, Lien E J, Lai M M C. J. Med. Chem., 1985, 28: 1103.

[13]

Zhou X, Shao L, Jin Z, Liu J B, Dai H, Fang J X. Heteroat. Chem., 2007, 18: 55.

[14]

Hu A X, Qin Z, Chen P, Ye J. Chin. J. Org. Chem., 2010, 30: 923.

[15]

Yang L T, Qin Z, Chen P, Hu A X. Chin. J. Appl. Chem., 2010, 27: 664.

[16]

Hu A X, Xu J P, Lin H B, Ye J. The Synthesis and Application of Thiazole Schiff Bases with Nitro-group, CN 101492426, 2009.

[17]

Hu A X, Cao G, Ma Y Q, Zhang J Y, Ou X M. Chin. J. Struct. Chem., 2008, 27: 1235.

[18]

Wang Y, Hu A X, Cao G, Li G X, Zhang J Y, Xia L, Ou X M, Xu J B. Chin. J. Org. Chem., 2008, 28: 443.

[19]

Hu A X, Cao G. Tetrahedron: Asymmetry, 2011, 22: 1332.

[20]

Hu A X, Cao G, Xu J J, Xia L, He D H. J. Hunan University, Natural Sciences, 2007, 34: 78.

AI Summary AI Mindmap
PDF

107

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/